Actemra 100mg, a treatment known scientifically as tocilizumab, represents a potent pharmaceutical agent primarily employed for the management of rheumatoid arthritis. This remarkable agent functions by blocking the activity of interleukin-6 (IL-6), a regulatory protein essential in the inflammatory process. Moreover, Actemra demonstrates promise